IL2 and cancer: The andrographolide shows better activity on signalling pathways like TLR4/NF-κB for insulinoma tumour28,29 and possess anti-cancer studies such as enhancement of cell differentiation, IL-2, IFN-c, tumour suppressor proteins P53 and P21.